Terms: = Breast cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Treatment
161 results:
1. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
Shuaib M; Chaudhri S; Kumar S
Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
[TBL] [Abstract] [Full Text] [Related]
2. Influence of copper(I) nicotinate complex on the notch1 signaling pathway in triple negative breast cancer cell lines.
Abdel-Mohsen MA; Badawy AM; Abu-Youssef MA; Yehia MA; Abou Shamaa LD; Mohamed SA
Sci Rep; 2024 Jan; 14(1):2522. PubMed ID: 38291201
[TBL] [Abstract] [Full Text] [Related]
3. Ectopic expression of tumor suppressive miR-181c-5p downregulates oncogenic Notch signaling in MDA-MB-231 cells.
Shuaib M; Kumar S
Pathol Res Pract; 2024 Jan; 253():155017. PubMed ID: 38101160
[TBL] [Abstract] [Full Text] [Related]
4. Bruceine D suppresses CAF-promoted TNBC metastasis under TNF-α stimulation by inhibiting notch1-Jagged1/NF-κB(p65) signaling.
Chen H; Han X; Zhang Y; Wang K; Liu D; Hu Z; Wang J
Phytomedicine; 2024 Jan; 123():154928. PubMed ID: 38043386
[TBL] [Abstract] [Full Text] [Related]
5. Dinuclear gold(I) complexes based on carbene and diphosphane ligands: bis[2-(dicyclohexylphosphano)ethyl]amine complex inhibits the proteasome activity, decreases stem cell markers and spheroid viability in lung cancer cells.
Casagrande N; Borghese C; Corona G; Aldinucci D; Altaf M; Sulaiman AAA; Isab AA; Ahmad S; Peedikakkal AMP
J Biol Inorg Chem; 2023 Dec; 28(8):751-766. PubMed ID: 37955736
[TBL] [Abstract] [Full Text] [Related]
6. Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer.
Hossain F; Ucar DA; Monticone G; Ran Y; Majumder S; Larter K; Luu H; Wyczechowska D; Heidari S; Xu K; Shanthalingam S; Matossian M; Xi Y; Burow M; Collins-Burow B; Del Valle L; Hicks C; Zabaleta J; Golde T; Osborne B; Miele L
Front Immunol; 2023; 14():1244159. PubMed ID: 37901240
[TBL] [Abstract] [Full Text] [Related]
7.
Chen B; Jiang K; Wang H; Miao L; Lin X; Chen Q; Jing L; Lu X
Front Biosci (Landmark Ed); 2023 Sep; 28(9):220. PubMed ID: 37796700
[TBL] [Abstract] [Full Text] [Related]
8. Matrine exerts an anti-tumor effect via regulating hn1 in triple breast cancer both in vitro and in vivo.
Guo Q; Yu Y; Tang W; Zhou S; Lv X
Chem Biol Drug Des; 2023 Dec; 102(6):1469-1477. PubMed ID: 37674344
[TBL] [Abstract] [Full Text] [Related]
9. Solid-Basaloid Adenoid Cystic Carcinoma of the breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression.
Shamir ER; Bean GR; Schwartz CJ; Vohra P; Wang A; Allard GM; Wolsky RJ; Garcia JJ; Chen YY; Krings G
Mod Pathol; 2023 Dec; 36(12):100324. PubMed ID: 37660928
[TBL] [Abstract] [Full Text] [Related]
10. Estrogen-Related Receptor Alpha (ERRα) Promotes cancer Stem Cell-Like Characteristics in breast cancer.
Muduli K; Prusty M; Pradhan J; Samal AP; Sahu B; Roy DS; Reddy KS; Elangovan S
Stem Cell Rev Rep; 2023 Nov; 19(8):2807-2819. PubMed ID: 37584854
[TBL] [Abstract] [Full Text] [Related]
11. Exploring the anti-cancer potential of dietary phytochemicals for the patients with breast cancer: A comprehensive review.
Sohel M; Aktar S; Biswas P; Amin MA; Hossain MA; Ahmed N; Mim MIH; Islam F; Mamun AA
Cancer Med; 2023 Jul; 12(13):14556-14583. PubMed ID: 37132286
[TBL] [Abstract] [Full Text] [Related]
12. Cooperative NF-κB and notch1 signaling promotes macrophage-mediated MenaINV expression in breast cancer.
Duran CL; Karagiannis GS; Chen X; Sharma VP; Entenberg D; Condeelis JS; Oktay MH
Breast Cancer Res; 2023 Apr; 25(1):37. PubMed ID: 37024946
[TBL] [Abstract] [Full Text] [Related]
13. Indolocarbazole alkaloid Loonamycin A inhibits triple-negative breast cancer cell stemness and Notch signalling.
Xue W; Li W; Yu Y; Zhang B; Wang Y; Zhou L; Chen Z; Wang L; Ge H; Xu Q; Shen Y
J Pharm Pharmacol; 2023 Apr; 75(4):523-532. PubMed ID: 36861187
[TBL] [Abstract] [Full Text] [Related]
14. Splicing factor SNRPA associated with microvascular invasion promotes hepatocellular carcinoma metastasis through activating notch1/Snail pathway and is mediated by circSEC62/miR-625-5p axis.
Mo Z; Li R; Cao C; Li Y; Zheng S; Wu R; Xue J; Hu J; Meng H; Zhai H; Huang W; Zheng F; Zhou B
Environ Toxicol; 2023 May; 38(5):1022-1037. PubMed ID: 36715182
[TBL] [Abstract] [Full Text] [Related]
15. Ezrin accelerates breast cancer liver metastasis through promoting furin-like convertase-mediated cleavage of notch1.
Chen M; Pan Y; Liu H; Ning F; Lu Q; Duan Y; Gan X; Lu S; Hou H; Zhang M; Tian Y; Lash GE
Cell Oncol (Dordr); 2023 Jun; 46(3):571-587. PubMed ID: 36580262
[TBL] [Abstract] [Full Text] [Related]
16. siRNA and targeted delivery systems in breast cancer therapy.
Mirzaei S; Paskeh MDA; Entezari M; Bidooki SH; Ghaleh VJ; Rezaei S; Hejazi ES; Kakavand A; Behroozaghdam M; Movafagh A; Taheriazam A; Hashemi M; Samarghandian S
Clin Transl Oncol; 2023 May; 25(5):1167-1188. PubMed ID: 36562927
[TBL] [Abstract] [Full Text] [Related]
17. A carbon monoxide releasing metal organic framework nanoplatform for synergistic treatment of triple-negative breast tumors.
Cong Y; Sun B; Hu J; Li X; Wang Y; Zhang J; Yang D; Lu W; Ding Z; Wang X; Hong H
J Nanobiotechnology; 2022 Nov; 20(1):494. PubMed ID: 36424645
[TBL] [Abstract] [Full Text] [Related]
18. RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling pathway.
Chen S; Cai K; Zheng D; Liu Y; Li L; He Z; Sun C; Yu C
Cell Death Dis; 2022 Nov; 13(11):945. PubMed ID: 36351890
[TBL] [Abstract] [Full Text] [Related]
19. Multi-Gene Mutation Profiling by Targeted Next-Generation Sequencing in Premenopausal breast cancer.
Zografos E; Andrikopoulou A; Papatheodoridi AM; Kaparelou M; Bletsa G; Liontos M; Dimopoulos MA; Zagouri F
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011273
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.
Zhang L; Sun S; Zhao X; Liu J; Xu Y; Xu L; Song C; Li N; Yu J; Zhao S; Yu P; Fang F; Xie J; Ji X; Yu R; Ou Q; Zhao Z; Li M
Mol Oncol; 2022 Oct; 16(20):3689-3702. PubMed ID: 35971249
[TBL] [Abstract] [Full Text] [Related]
[Next]
